BRIEF published on 07/11/2024 at 07:10, 2 months 8 days ago Heidelberg Pharma rend compte du premier semestre 2024 et de la marche des affaires Résultats Financiers Essai Clinique Heidelberg Pharma HDP-101 Myélome Multiple
BRIEF published on 07/11/2024 at 07:10, 2 months 8 days ago Heidelberg Pharma Reports on First Half-Year 2024 and the Course of Business Financial Results Clinical Trial Heidelberg Pharma HDP-101 Multiple Myeloma
PRESS RELEASE published on 07/11/2024 at 07:05, 2 months 8 days ago Heidelberg Pharma Reports on First Half-Year 2024 and the Course of Business Heidelberg Pharma AG reports positive preliminary efficacy data for HDP-101 in multiple myeloma clinical trial. Key events include AACR Meeting presentation & FDA Orphan Drug Designation Clinical Trial HDP-101 Heidelberg Pharma AG AACR Meeting FDA Orphan Drug Designation
BRIEF published on 06/21/2024 at 11:21, 2 months 28 days ago Heidelberg Pharma rend compte des résultats de l'Assemblée générale annuelle 2024 Actionnaires Resolutions Heidelberg Pharma Actualités Financières AGA 2024
BRIEF published on 06/21/2024 at 11:21, 2 months 28 days ago Heidelberg Pharma Reports on the Results of the Annual General Meeting 2024 Shareholders Financial News Resolutions Heidelberg Pharma AGM 2024
PRESS RELEASE published on 06/21/2024 at 11:16, 2 months 28 days ago Heidelberg Pharma reports on the results of the Annual General Meeting 2024 Heidelberg Pharma AG reports on the results of the Annual General Meeting 2024, including approval of resolutions and shareholder attendance Shareholders Voting Results Annual General Meeting 2024 Cancer Therapy Heidelberg Pharma AG
BRIEF published on 06/18/2024 at 13:52, 3 months 1 day ago Heidelberg Pharma AG annonce des prévisions mises à jour pour 2024 Conseils Financiers Prévisions De Revenus Heidelberg Pharma SA Biotechnologies Dépenses De Fonctionnement
BRIEF published on 06/18/2024 at 13:52, 3 months 1 day ago Heidelberg Pharma AG Announces Updated Guidance for 2024 Revenue Forecast Financial Guidance Biotech Heidelberg Pharma AG Operating Expenses
PRESS RELEASE published on 06/18/2024 at 13:47, 3 months 1 day ago EQS-Adhoc: Heidelberg Pharma AG announces updated guidance Heidelberg Pharma AG updates guidance for fiscal year 2024, lowering sales expectations due to delays and adjusting operating expenses. Financing secured until mid-2025 with potential expansion until end of 2026 Financial Year 2024 Heidelberg Pharma AG Operating Expenses Sales Expectations Updated Guidance
BRIEF published on 05/23/2024 at 09:17, 3 months 27 days ago Heidelberg Pharma to Participate and Present at Upcoming Leading Scientific Conferences in May and June 2024 Cancer Treatment Conférences Heidelberg Pharma HDP-101 ADCs
Published on 09/19/2024 at 17:30, 1 hour 18 minutes ago Airborne Geophysical Survey Completed at Pine Channel Gold Project, Saskatchewan
Published on 09/19/2024 at 17:00, 1 hour 48 minutes ago Cypress Creek Consulting Advises Charter Communications on Inaugural Securitization Financing Facility
Published on 09/19/2024 at 15:45, 3 hours 3 minutes ago eLearners Make eLearning a Daily or Weekly Habit, Voices' eLearning Report Finds
Published on 09/19/2024 at 15:20, 3 hours 28 minutes ago Taurus secures "Best Digital Assets Solution" at 2024 Global BankTech Awards
Published on 09/19/2024 at 15:01, 3 hours 47 minutes ago ful. CashPay: Revolutionizing Healthcare Access for Employers With Uninsured Team Members
Published on 09/19/2024 at 17:52, 55 minutes ago PILOT 28 : FIGEAC AÉRO remporte 3 nouveaux contrats sur l'A320 pour 65 millions d'euros
Published on 09/19/2024 at 17:52, 55 minutes ago PILOT 28: FIGEAC AÉRO secures 3 new wins on the A320 airframe for 65 million euros
Published on 09/19/2024 at 17:52, 56 minutes ago EQS-Adhoc: SMT Scharf AG: New CEO joins the Managing Board
Published on 09/19/2024 at 17:45, 1 hour 2 minutes ago AFG Holding SA acquiert une participation majoritaire dans le groupe allemand Access Holding et prend ainsi le contrôle de
Published on 09/19/2024 at 17:45, 1 hour 3 minutes ago Gimv draagt helft van participatie in Infravest over aan WorxInvest (communicatie in toepassing van artikel 7:97 WVV)
Published on 09/19/2024 at 17:45, 1 hour 3 minutes ago Gimv sells half of participation in Infravest to WorxInvest (communication pursuant to article 7:97 BCAC)
Published on 09/19/2024 at 17:45, 1 hour 3 minutes ago Gimv sells half of participation in Infravest to WorxInvest (communication pursuant to article 7:97 BCAC)